#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)April 23, 2024

 

 #### Basel, Switzerland

 

 

Novartis announced the company’s financial results for the first quarter of 2024.

 

 

 [    Media release  (295 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-en.pdf) [    Medienmitteilung  (323 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-de.pdf) [    Communiqué de presse  (371 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2024-media-release-fr.pdf) 

 



 [    Interim financial report  (376 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/2024-04-interim-financial-report-en.pdf) 

 



---

## Investors

[Watch the webcast](https://edge.media-server.com/mmc/p/dngt7jjp/)  
14:00 CEST | 13:00 BST | 08:00 EDT

[Download the podcast (MP3 30 MB)](https://prod1.novartis.com/sites/novartis_com/files/2024-04/q1-2024-investor-presentation.mp3)  
[Read the transcript](/investors/financial-data/quarterly-results/2024-q1-transcript "2024 Q1 results presentation and transcript")



[Download the presentation (PDF 6.0 MB)](/sites/novartis_com/files/q1-2024-investor-presentation.pdf "q1-2024-investor-presentation.pdf")

[Novartis Q1 2024 impact and sustainability update (PDF 1.4 MB)](https://prod1.novartis.com/sites/novartis_com/files/novartis-q1-2024-impact-and-sustainability-update.pdf)









 



 [ 

 

###  Novartis Pipeline 

Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.

 

 

 ](https://www.novartis.com/research-development/novartis-pipeline) [ 

 

###  Executive Committee of Novartis (ECN) biographies 

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.

 

 

 ](/about/executive-committee) 





 

 [Download the Novartis Pipeline as of December 31, 2023 (PDF 0.1 MB)](/sites/novartis_com/files/novartis-pipeline-2023-annual-report.pdf "Download the Novartis Pipeline as of December 31, 2023 (PDF 0.1 MB)")